ANIXA BIOSCIENCES, INC. Derivative Liability
ANIXA BIOSCIENCES, INC. (ANIX) had Derivative Liability of $3.43 million as of 2014-01-31, per its 10-Q filed 2014-03-17.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2015-01-29
- 2014-01-31: Derivative Liability $3.43M.
- 2013-10-31: Derivative Liability $540.00K.
- 2013-07-31: Derivative Liability $700.00K.
| Period end | Derivative Liability |
|---|---|
| 2014-01-31 | $3.43M 10-Q · filed 2014-03-17 |
| 2013-10-31 | $540.00K 10-K · filed 2015-01-29 |
| 2013-07-31 | $700.00K 10-Q/A · filed 2013-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |